Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Endosomal recognition of viral single stranded (ss) RNA occu...
| Class:Id | Summation:188745 |
|---|---|
| _displayName | Endosomal recognition of viral single stranded (ss) RNA occu... |
| _timestamp | 2021-10-02 02:37:56 |
| created | [InstanceEdit:188744] de Bono, B, 2006-10-27 09:50:22 |
| literatureReference | [LiteratureReference:9684918] Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands [LiteratureReference:9684922] Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands [LiteratureReference:9684913] Autoinhibition and relief mechanism by the proteolytic processing of Toll-like receptor 8 [LiteratureReference:9684923] Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA [LiteratureReference:9684933] Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response [LiteratureReference:188142] Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA [LiteratureReference:188148] Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway [LiteratureReference:188159] Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 [LiteratureReference:188144] Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 [LiteratureReference:9710580] Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon [LiteratureReference:9710577] High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus [LiteratureReference:9710572] Toll-like receptors in antiviral innate immunity [LiteratureReference:9710568] Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes [LiteratureReference:9710557] Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8 [LiteratureReference:9678611] Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo [LiteratureReference:9684981] Hydroxychloroquine: a multifaceted treatment in lupus [LiteratureReference:9754736] SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway |
| modified | [InstanceEdit:9684912] Shamovsky, Veronica, 2020-04-22 [InstanceEdit:9710578] Shamovsky, Veronica, 2021-01-05 [InstanceEdit:9713605] Shamovsky, Veronica, 2021-01-27 [InstanceEdit:9754735] Shamovsky, Veronica, 2021-10-02 |
| text | Endosomal recognition of viral single stranded (ss) RNA occurs by means of toll-like receptor 7 (TLR7) and TLR8. TLR7 and TLR8 detect GU-rich ssRNA sequences from the viral genomes of orthomyxovirus (influenza A), lentivirus (human immunodeficiency virus-1, HIV-1), vesiculovirus (vesicular stomatitis virus, VSV), enterovirus (coxsackie B virus), betacoronavirus (severe acute respiratory syndrome-associated coronavirus type 1, SARS-CoV-1 and SARS-CoV-2) and flavivirus (HCV and WNV) (Hemmi H et al. 2002; Jurk M et al. 2002; Diebold SS et al. 2004; Heil F et al. 2004; Cervantes-Barragan L et al. 2007; Li Y et al. 2013; Scheuplein VA et al. 2015; Campbell GR et al. 2021; reviewed in Lester SN & Li K 2014). Specifically, GU-rich ssRNA oligonucleotides derived from HIV-1, for example, stimulate dendritic cells (DC) and macrophages to secrete interferon-alpha and proinflammatory, as well as regulatory, cytokines (Heil F et al. 2004). This has been found to be mediated by TLR7, as well as TLR8. Similarly, ssRNA derived from SARS‑CoV‑1 induced mononuclear phagocytes to release considerable levels of pro‑inflammatory cytokines TNF‑a, IL‑6 and IL‑12 via TLR7 and TLR8 (Li Y et al. 2013). Bioinformatics scanning techniques showed that the SARS‑CoV‑2 genome contains a large number of fragments that could be recognized by TLR7/TLR8 (Moreno‑Eutimio MA et al. 2020). In human macrophages, GU-rich RNA derived from SARS-CoV-2, SARS-CoV-1, and HIV-1 triggered TLR8-mediated pro-inflammatory responses leading to activation of the NLRP3 inflammasome and IL-1β secretion (Campbell GR et al. 2021). Upon engagement of ssRNAs in endosomes, TLR7 and TLR8 initiate the MyD88‑dependent pathway, leading to production of type I and type III IFNs and proinflammatory mediators via activation of IRF7 and NF‑κB, respectively (reviewed in Lester SN & Li K 2014). In addition, imidazoquinoline compounds (e.g. imiquimod and R‑848, a small‑molecule immune response modifier that can induce the synthesis of interferon‑alpha) were reported to be ligands of TLR7 and TLR8 (Hemmi H et al. 2002; Jurk M et al. 2002; Diebold SS et al. 2004). Structural analyses have revealed that both TLR7 and TLR8 possess two binding sites (Zhang Z et al. 2016). Binding site 1 is highly conserved between TLR7 and TLR8 and binds nucleosides (guanosine (G) for TLR7 and uridine (U) for TLR8) or base analogs. Binding site 2 of TLR7 and TLR8 is less conserved and binds ssRNA with U(U) and U(G) motifs. TLR7 acts as a dual receptor for G and U‑containing ssRNAs. Binding of ssRNA to the site 2 of TLR7 strongly enhances the interaction of TLR7 and G at the first site leading to subsequent receptor dimerization. Conversely, chemical ligands are sufficiently potent to induce TLR7 dimerization by binding to the first site alone (Zhang Z et al. 2016, 2018). Further, upon ligand stimulation, the TLR8 dimer was reorganized such that the two C termini were brought into proximity (Tanji H et al. 2013). The loop between leucine‑rich repeat 14 (LRR14) and LRR15 was cleaved, but the N‑ and C‑terminal halves remained associated and contributed to ligand recognition and dimerization, which enables the downstream signaling activation of IRF and NF‑κB (Tanji H et al. 2013, 2016). Although TLR7 and TLR8 share structural homology and both sense viral GU-rich ssRNA, their binding affinities to TLR7/TLR8 ligands may differ (Li Y et al. 2013; Campbell GR et al. 2021). TLR7‑specific ligands generally induce IFN‑regulated cytokines, but TLR8‑specific ligands lead primarily to the production of proinflammatory cytokines (Gorden KB et al. 2005). Hydroxychloroquine (HCQ) binds and antagonizes TLR7 (Lamphier M et al. 2014), and thus inhibits interferon alpha production. HCQ is used clinically to treat systemic lupus erythromatosis and other autoimmune disorders (Costedoat‑Chalumeau N et al. 2014). |
| (summation) | [Reaction:167983] C-ter TLR7 dimer binds TLR7, TLR8 ligands [Homo sapiens] |
| [Change default viewing format] | |
